Small intestinal injury caused by NSAIDs/aspirin: Finding new from old

Current Medicinal Chemistry

Volumn 19, Issue 1, 2012, Pages 77-81

  Arakawa, T ^a   Watanabe, T ^a   Tanigawa, T ^a   Tominaga, K ^a   Otani, K ^a   Nadatani, Y ^a   Fujiwara, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aspirin; Cyclooxygenase; Injury; Mitochondria; NSAID; Prostaglandin; Small intestine

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 2,4 DINITROPHENOL; ACETYLSALICYLIC ACID; AMINOGUANIDINE; ANTISERUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; HEAT SHOCK PROTEIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; LANSOPRAZOLE; MISOPROSTOL; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROTON PUMP INHIBITOR; REACTIVE OXYGEN METABOLITE; REBAMIPIDE; TEPRENONE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BILE; CAPSULE ENDOSCOPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; INTESTINE CELL; INTESTINE INJURY; MITOCHONDRION; NEUTROPHIL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; SMALL INTESTINE; ULCER;

EID: 84863281966     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414105     Document Type: Article

References (52)

1. Shack, M.E. Drug induced ulceration and perforation of the small intestine. Ariz Med., 1966, 23(7), 517-523.
2. Taylor L.A.; Crawford, L.M. Aspirin-induced gastrointestinal lesions in dogs. J Am Vet Med Assoc., 1968, 152(6), 617-619.
3. Chapman, D.G.; Shenoy, K.G.; Campbell, J.A. Sustained release of drugs in certain drug-resin complexes as judged by urinary excretion rates. Can Med Assoc J., 1959, 81, 470-477.
4. Yesair, D.W.; Remington, L.; Callahan, M.; Kensler, C.J. Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats. Biochem Pharmacol., 1970, 19, 1591-1600.
5. Ivey, K.J.; Baskin, W.N.; Krause, W.J.; Terry, B. Effect of aspirin and acid on human jejunal mucosa. An ultrastructural study. Gastroenterology, 1979, 76(1), 50-56. (Pubitemid 9129534)
6. Graham, D.Y; Opekun, A.R.; Willingham, F.F.; Qureshi, W.A. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Clin Gastroenterol Hepatol., 2005, 3(1), 55-59.
7. Leung, W.K; Bjarnason, I.; Wong, V.W. Sung JJ, Chan FK. Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet, 2007, 369(9561), 614. (Pubitemid 46241446)
8. Yamada, T.; Deitch, E.; Specian, R.D.; Perry, M.A.; Sartor, R.B.; Grisham, M.B. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation, 1993, 17(6), 641-662. (Pubitemid 23359088)
9. Jacob, M.; Foster, R.; Sigthorsson, G.; Simpson, R.; Bjarnason, I. Role of bile in pathogenesis of indomethacin-induced enteropathy Arch Toxicol., 2007, 81(4), 291-298. (Pubitemid 46434776)
10. Somasundaram, S.; Sigthorsson, G.; Simpson, R.J.; Watts, J.; Jacob, M.; Tavares, I.A.; Rafi, S.; Roseth, A.; Foster, R.; Price, A.B.; Wrigglesworth, J.M.; Bjarnason, I. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther., 2000, 14(5), 639-650. (Pubitemid 30240758)
11. Zhou, Y.; Dial, E.J.; Doyen, R.; Lichtenberger, L.M. Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs. Am J Physiol Gastrointest Liver Physiol., 2010, 298(5), G722-731.
12. Nonoyama, K.; Nakagawa, K.; Amagase, K.; Takeuchi, K.; Nakamura, M.; Okabe, S. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin. J Gastroenterol Hepatol., 2010, 25 Suppl 1, S15-22.
13. Endo, H.; Hosono, K.; Inamori, M.; Nozaki, Y.; Yoneda, K.; Fujita, K.; Takahashi, H.; Yoneda, M.; Abe, Y.; Kirikoshi, H.; Kobayashi, N.; Kubota, K.; Saito, S.; Ohya, T.; Hisatomi, K.; Teratani, T.; Matsuhashi, N.; Nakajima, A. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol., 2009, 44(6), 544-549.
14. Brodie, D.A.; Tate, C.L.; Hooke, K.F. Aspirin: intestinal damage in rats. Science, 1970, 170(954), 183-185.
15. Robert, A.; Nezamis, J.E.; Lancaster, C.; Hanchar , A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology, 1979, 77(3), 433-443. (Pubitemid 10132046)
16. Robert, A. An intestinal disease produced experimentally by a prostaglandin deficiency. Gastroenterology, 1975, 69(4), 1045-1047.
17. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology, 2000, 119(3), 706-714.
18. Tanaka, A.; Hase, S.; Miyazawa, T.; Takeuchi, K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther., 2002, 300(3), 754-761. (Pubitemid 34164976)
19. Takeuchi, K.; Miyazawa, T.; Tanaka, A.; Kato, S.; Kunikata, T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion, 2002, 66(1), 30-41. (Pubitemid 36151288)
20. Whittle, B.J. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 1981, 80(1), 94-98. (Pubitemid 11213294)
21. Reuter, B.K.; Davies, N.M.; Wallace, J.L. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997, 112(1), 109-117. (Pubitemid 27008992)
22. Somasundaram, S.; Rafi,S.; Hayllar, J.; Sigthorsson, G.; Jacob, M.; Price, A.B.; Macpherson, A.; Mahmod, T.; Scott, D.; Wrigglesworth, J.M.; Bjarnason I. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut. 1997, 41(3), 344-353. (Pubitemid 27428194)
23. Bjarnason, I.; Hayllar, J.; MacPherson, A.J.; Russell, A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993, 104(6), 1832-1847. (Pubitemid 23235480)
24. Watanabe, T.; Tanigawa, T.; Nadatani, Y.; Otani, K.; Machida, H.; Okazaki, H.; Yamagami, H.; Watanabe, K.; Tominaga, K.; Fujiwara, Y.; Arakawa, T. Mitochondrial disorders in NSAIDs-induced small bowel injury. J Clin Biochem Nutr., 2011, 48(2), 117-121.
25. Kent, T.H.; Cardelli, R.M.; Stamler, F.W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol., 1969, 54(2):237-249.
26. Konaka, A.; Kato, S.; Tanaka, A.; Kunikata, T.; Korolkiewicz, R.; Takeuchi, K. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res., 1999, 40(6), 517-524.
27. Robert, A.; Asano, T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins, 1977, 14(2), 333-341. (Pubitemid 8171147)
28. Watanabe, T.; Nishio, H.; Tanigawa, T.; Yamagami, H.; Okazaki, H.; Watanabe, K.; Tominaga, K.; Fujiwara, Y.; Oshitani, N.; Asahara, T.; Nomoto, K.; Higuchi, K.; Takeuchi, K.; Arakawa, T. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol., 2009, 297(3), G506-513.
29. Watanabe, T.; Higuchi, K.; Kobata, A.; Nishio, H.; Tanigawa, T.; Shiba, M.; Tominaga, K.; Fujiwara, Y.; Oshitani, N.; Asahara, T.; Nomoto, K.; Takeuchi, K.; Arakawa, T. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut, 2008, 57(2), 181-187 (Pubitemid 351158044)
30. Wallace, J.L.; Denou, E.; Vong, L.; Syer, S.; McKnight, W.; Jury, J.; Verdu, E., Bercik, P.; Collins, S.M.; Bolla, M.; Ongini, E. Proton pump inhibitors and low-dose aspirin markedly exacerbate NSAID-induced small intestinal injury: Link to dysbiosis? Gastroenterology, 2011, in press.
31. Lombardo, L; Foti, M.; Ruggia, O.; Chiecchio, A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol., 2010, 8(6), 504-508.
32. Pozzoli, C.; Menozzi, A.; Grandi, D.; Solenghi, E.; Ossiprandi, M.C.; Zullian, C.; Bertini, S.; Cavestro, G.M.; Coruzzi, G. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol., 2007, 374(4), 283-291. (Pubitemid 46089466)
33. Yoda, Y.; Amagase, K.; Kato, S.; Tokioka, S.; Murano, M.; Kakimoto, K.; Nishio, H.; Umegaki, E.; Takeuchi, K.; Higuchi, K. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1. J Physiol Pharmacol., 2010, 61(3), 287-294.
34. Kato, S.; Ito, Y.; Nishio, H.; Aoi, Y.; Amagase, K.; Takeuchi, K. Increased susceptibility of small intestine to NSAID-provoked ulceration in rats with adjuvant-induced arthritis: involvement of enhanced expression of TLR4. Life Sci., 2007, 81(16), 1309-1316. (Pubitemid 47539505)
35. Fukumoto, K.; Naito, Y.; Takagi, T.; Yamada, S.; Horie, R.; Inoue, K.; Harusato, A.; Hirata, I.; Omatsu, T.; Mizushima, K., Hirai, Y.l Yoshida, N.; Uchiyama, K.; Ishikawa, T.; Handa, O.; Konishi, H.; Wakabayashi, N.; Yagi, N.; Kokura, S.; Ichikawa, H.; Kita, M.; Yoshikawa, T. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice. Int J Mol Med., 2011, 27(3), 353-359.
36. Watanabe, T.; Nagami, Y.; Sugimori, S.; Kameda, N.; Okazaki, H.; Machida, H.; Yamagami, H.; Tanigawa, T.; Watanabe, K.; Tominaga, K.; Koike, T.; Arakawa, T. NSAID-Induced Small Bowel Injury Is Reduced in Patients with Rheumatoid Arthritis Receiving Anti-Tumor Necrosis Factor-alpha Therapy. Gastroenterology, 2009, 136(5), A715.
37. Goldstein, J.L.; Eisen, G.M.; Lewis, B.; Gralnek, I.M.; Zlotnick, S.; Fort, J.G. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol., 2005, 3(2), 133-141. (Pubitemid 40220308)
38. Fujimori, S.; Seo, T.; Gudis, K.; Ehara, A.; Kobayashi, T.; Mitsui, K.; Yonezawa, M.; Tanaka, S.; Tatsuguchi, A.; Sakamoto, C. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc. 2009, 69(7), 1339-1346.
39. Watanabe, T.; Sugimori, S.; Kameda, N.; Machida, H.; Okazaki, H.; Tanigawa, T.; Watanabe, K.; Tominaga, K.; Fujiwara, Y.; Oshitani, N.; Higuchi, K.; Arakawa, T. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol., 2008, 6(11), 1279-1282.
40. Niwa, Y.; Nakamura, M.; Ohmiya, N.; Maeda, O.; Ando, T.; Itoh, A.; Hirooka, Y.; Goto, H. Efficacy of rebamipide for diclofenac-induced smallintestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol., 2008, 43(4), 270-276. (Pubitemid 351650037)
41. Fujimori, S.; Takahashi, Y.; Gudis, K.; Seo, T.; Ehara, A.; Kobayashi, T.; Mitsui, K.; Yonezawa, M.; Tanaka, S.; Tatsuguchi, A.; Sakamoto, C. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gastroenterol., 2011, 46(1), 57-64.
42. Arakawa, T.; Higuchi, K.; Fujiwara, Y.; Watanabe, T.; Tominaga, K.; Sasaki, E.; Oshitani, N.; Yoshikawa, T.; Tarnawski, A.S. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci. 2005, 50 (Suppl 1), S3-S11. (Pubitemid 41380792)
43. Arakawa, T.; Kobayashi, K.; Yoshikawa, T.; Tarnawski, A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci., 1998, 43(Suppl 9), S5-13.
44. Mizuno, H.; Sakamoto, C.; Matsuda, K.; Wada, K.; Uchida, T.; Noguchi, H.; Akamatsu, T.; Kasuga, M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology, 1997, 112(2), 387-397. (Pubitemid 27078825)
45. Sun, W.H.; Tsuji, S.; Tsujii, M.; Gunawan, E.S.; Kawai, N.; Kimura, A.; Kakiuchi, Y.; Yasumaru, M.; Iijima, H.; Okuda, Y.; Sasaki, Y.; Hori, M.; Kawano, S. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther., 2000, 295(2), 447-452.
46. Watanabe, T.; Higuchi, K.; Taira, K.; Sasaki, E.; Shiba, M.; Tominaga, K.; Fujiwara, Y.; Oshitani, N.; Arakawa, T. Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice. Dig Dis Sci., 2005, 50 (Suppl 1), S63-69. (Pubitemid 41380800)
47. Tanigawa, T.; Watanabe, T.; Ohkawa, F.; Nadatani, Y.; Otani, K.; Machida, H.; Okazaki, H.; Yamagami, H.; Watanabem K.; Tominaga, K.; Fujiwara, Y.; Takeuchi, K.; Arakawa, T. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase. J Clin Biochem Nutr., 2011, 48(2), 149-153.
48. Shiotani, A.; Haruma, K.; Nishi, R.; Fujita, M.; Kamada, T.; Honda, K.; Kusunoki, H.; Hata, J.; Graham, D.Y. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose entericcoated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol., 2010, 45(3), 292-298.
49. Bing, S.R.; Kinouchi, T.; Kataoka, K.; Kuwahara, T.; Ohnishi, Y. Protective effects of a culture supernatant of Lactobacillus acidophilus and antioxidants on ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol., 1998, 42(11), 745-753. (Pubitemid 28547597)
50. Leite, A.Z.; Sipahi, A.M.; Damião, A.O.; Coelho, A.M.; Garcez, A.T.; Machado, M.C.; Buchpiguel, C.A.; Lopasso, F.P.; Lordello, M.L.; Agostinho, C.L.; Laudanna, A.A. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut, 2001, 48(2), 163-167. (Pubitemid 32143727)
51. LoGuidice, A.; Ramirez-Alcantara, V.; Proli, A.; Gavillet, B.; Boelsterli, U.A. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice. Toxicol Sci., 2010, 118(1), 276-285.
52. Ramirez-Alcantara, V.; LoGuidice, A.; Boelsterli, U.A. Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy. Am J Physiol Gastrointest Liver Physiol., 2009, 297(5), G990-998.